ISSN : 0970 - 020X, ONLINE ISSN : 2231-5039
     FacebookTwitterLinkedinMendeley

Abstract

Method Development and Validation for the Simultaneous Estimation of Cinitapride and Pantoprazole in Solid Dosage Forms By RP-HPLC

Suryadevara Vidyadhara1*, Yarraguntla Srinivasa Rao2, Anne Ramu1, Reddyvalam Lankapalli Sasidhar1 and Anne Jaya Ramya1

DOI : http://dx.doi.org/10.13005/ojc/290355


Abstract:

A new rapid, precise and sensitive reverse phase high performance liquid chromatographic (RP-HPLC) method has been developed and validated for the estimation of cinitapride and pantoprazole simultaneously in combined dosage form. The two components cinitapride and pantoprazole were well resolved on an isocratic C18 column, utilizing a mobile phase composition of acetonitrile: phosphate buffer (50:50, v/v, pH 6.8) at a flow rate of 1.0 mL/min with UV detection at 281 nm. The retention time of cinitapride and pantoprazole were 4.5min and 5.4min respectively. The developed method was validated for specificity, linearity, precision, accuracy, limit of detection (LOD), limit of quantification (LOQ) and robustness as per ICH guidelines.  Linearity for cinitapride and pantoprazole were found in the range of 1.5-10.5μg/ml and 20-140μg/ml, respectively. The percentage recoveries for cinitapride and pantoprazole ranged from 97.9-103.44 % and 98.9-103.1%, respectively. The proposed method could be used for routine analysis of cinitapride and pantoprazole in their combined dosage forms.

Keywords:

Cinitapride;Pantoprazole;RP-HPLC

[ View HTML Full Text]

Back to TOC